Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00053417
Status:
COMPLETED
Last Update Posted:
2011-08-04
First Post:
2003-01-29
Brief Title:
Safety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple Sclerosis
Sponsor:
Acorda Therapeutics
Organization:
Acorda Therapeutics
Organization Data
Organization:
Acorda Therapeutics
Class:
INDUSTRY
Study ID:
MS-F202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Acorda Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Andrew BlightChief Scientific Officer
Old Organization:
Acorda Therapeutics